Seasonal variation in biopsy-proven giant cell arteritis in Eastern Denmark from 1990-2018
- PMID: 33211398
- DOI: 10.1111/aos.14675
Seasonal variation in biopsy-proven giant cell arteritis in Eastern Denmark from 1990-2018
Abstract
Purpose: The purpose of this study was to investigate seasonal variation in cases of biopsy-proven GCA in eastern Denmark in a 29-year period.
Methods: Pathology records of all temporal artery biopsies in eastern Denmark between 1990 and 2018 were reviewed. For each patient, data were collected which included age, sex, date of birth and biopsy result. Seasonality was evaluated using logistic regression and Poisson regression analysis. Lastly, an explorative pilot study was conducted to investigate a possible association between three weather parameters (average temperature, amount of rain and hours of sunshine) and the biopsy outcome.
Results: One thousand three hundred twenty-three biopsies were included of which 336 fulfilled objective criteria for GCA diagnosis. Mean age at diagnosis was 75.6 years (range 52-94 years). Among the biopsy-proven cases of GCA, there were 223 women (66.3%, mean age 76.2 years) and 113 men (33.7%, mean age 74.4 years) giving a female to male ratio of 1.97:1. The peak occurrence of GCA was in the 70-79 years age group. Statistical analysis of seasonal variation showed an increased risk of a positive biopsy during summer compared to autumn (p = 0.037). No association between the three weather parameters and the biopsy outcome was found.
Conclusion: In this study of biopsy-proven GCA in a large Danish patient cohort, the occurrence of GCA showed seasonal variation with higher occurrence in the summer months when compared to autumn. Future studies pooling all cases of GCA worldwide are needed to determine seasonality in the occurrence of GCA.
Keywords: arteritis temporalis; giant cell arteritis; seasonal variation; seasonality.
© 2020 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Abdul-Rahman AM, Molteno AC & Bevin TH (2011): The epidemiology of giant cell arteritis in Otago, New Zealand: a 9-year analysis. N Zeal Med J (Online) 124: 44-52.
-
- Bas-Lando M, Breuer G, Berkun Y, Mates M, Sonnenblick M & Nesher G (2007): The incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal fluctuations. Clin Exp Rheumatol 25: S15-17.
-
- Borchers AT & Gershwin ME (2012): Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment. Autoimmun Rev 11: A544-554.
-
- Carmona FD, Mackie SL, Martin JE et al. (2015): A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility. Am J Hum Genet 96: 565-580.
-
- Catanoso M, Macchioni P, Boiardi L et al. (2017): Incidence, prevalence, and survival of biopsy-proven giant cell arteritis in Northern Italy during a 26-year period. Arthritis Care Res (Hoboken) 69: 430-438.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical